...
首页> 外文期刊>Cellular Physiology and Biochemistry >Promotion of Tumor Growth by ADAMTS4 in Colorectal Cancer: Focused on Macrophages
【24h】

Promotion of Tumor Growth by ADAMTS4 in Colorectal Cancer: Focused on Macrophages

机译:ADAMTS4促进结直肠癌肿瘤生长的研究:以巨噬细胞为重点

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background/Aims ADAMTSs (A disintegrin and metalloprotease domains with thrombospondins motifs) are a family of extracellular proteases that have been related to both oncogenic and tumor-suppressive functions. The aim of the present study was to investigate 1) the mutation, copy-number alterations, and expression profile of ADAMTSs in colorectal cancer and 2) whether ADAMTSs participate in colorectal cancer (CRC) progression and invasion. Methods The mutation, copy-number alterations, and expression profile of ADAMTSs in CRC were analyzed in the TCGA cohort using cBioportal. ADAMTS4 expression in tumor tissues and cell lines were determined by immunostaining and real-time quantitative PCR. The role of ADAMTS-4 in CRC progression and the underlying mechanisms were studied by using short hairpin RNA-mediated knockdown of ADAMTS4. The effects of ADAMTS4 in cell proliferation and invasion were determined by clone formation assay and transwell migration assay, respectively. Macrophages were depleted by liposomal clodronate in immune-competent BALB/c mice and tumor growth was analyzed. Results ADAMTS4 was differentially expressed in CRC and predicted a poor prognosis. Elevated ADAMTS4 expression was closely associated with larger tumor size, enhanced TNM stage, and a poor clinical outcome in patients with CRC. ADAMTS4 knockdown had no inhibitory implications on cell proliferation and invasion in vitro, but significantly attenuated tumor growth in vivo. Mechanistically, we revealed that ADAMTS4 was associated macrophages infiltration and polarization in the tumor microenvironment of CRC. Macrophage depletion largely abolished the promotive effect of ADAMTS4 on tumor growth in the immune competent BALB/c mice. Conclusion ADAMTS4 seemed to be a promising prognostic indicator in CRC. The novel link between ADAMTS4 and macrophages mirrors the potential regulatory roles of ADAMTSs in the inflammatory microenvironment of cancers.
机译:背景/目的ADAMTS(具有血小板反应蛋白基序的双整合蛋白和金属蛋白酶结构域)是一类与致癌和肿瘤抑制功能相关的细胞外蛋白酶。本研究的目的是调查1)ADAMTS在结直肠癌中的突变,拷贝数变化和表达谱,以及2)ADAMTS是否参与结直肠癌(CRC)的进展和侵袭。方法使用cBioportal软件在TCGA队列中分析CRC中ADAMTS的突变,拷贝数变化和表达谱。通过免疫染色和实时定量PCR确定ADAMTS4在肿瘤组织和细胞系中的表达。通过使用短发夹RNA介导的ADAMTS4敲低研究了ADAMTS-4在CRC进展中的作用及其潜在机制。分别通过克隆形成测定和transwell迁移测定来确定ADAMTS4在细胞增殖和侵袭中的作用。巨噬细胞被具有免疫能力的BALB / c小鼠的氯膦酸盐脂质体耗尽,并分析了肿瘤的生长。结果ADAMTS4在CRC中表达差异,预后不良。 CRC患者中,ADAMTS4表达升高与更大的肿瘤尺寸,增强的TNM分期和不良的临床预后密切相关。 ADAMTS4基因敲低对体外细胞增殖和侵袭没有抑制作用,但可显着减弱体内肿瘤的生长。从机制上讲,我们发现ADAMTS4在CRC肿瘤微环境中与巨噬细胞浸润和极化有关。巨噬细胞耗竭在很大程度上消除了ADAMTS4对具有免疫能力的BALB / c小鼠的肿瘤生长的促进作用。结论ADAMTS4似乎是CRC的有前途的预后指标。 ADAMTS4和巨噬细胞之间的新颖联系反映了ADAMTS在癌症的炎症微环境中的潜在调节作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号